Chargement en cours...
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma
BACKGROUND: Following resection of liver metastases from colorectal cancer, 5-year survivals are reportedly 30 – 39%. It can be assumed that this clinical situation represents systemic disease. Therefore, it is postulated that systemic chemotherapy would improve outcomes, particularly in those whose...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC476737/ https://ncbi.nlm.nih.gov/pubmed/15245580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-4-32 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|